| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-05 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.19 |
0.0001 |